Skip to content
DefDex

Federal award

PEREGRINE PHARMACEUTICALS, INC.

HDTRA108C0003

Contract

Obligated and Ceiling

Obligated (net)
$24,633,972.00
Ceiling (potential value, not spending)
$35,028,564.87
Current value
$24,825,449.51
Gross positive obligations
$24,825,449.08

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
PEREGRINE PHARMACEUTICALS, INC. · UDX6JRKSFC77
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
PEREGRINE PHARMACEUTICALS, INC. · UDX6JRKSFC77
Awarding agency
Department of War · sub-agency 9761 · office HDTRA1
Funding agency
Department of War · sub-agency 9761
Product or service (PSC)
AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Industry (NAICS)
541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
PIID
HDTRA108C0003
Award type code
D
Actions
17 · Jun 30, 2008 to Jun 10, 2019
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History17

Award actions
DateFYModAction typeObligationCompany in company totals
Jun 10, 2019FY2019P00015C$94,121.08
—
May 21, 2019FY2019ARZ998W$0.00
—
Dec 14, 2015FY2016P00014M−$191,477.08
—
Jun 3, 2011FY2011P00013M$0.00
—
Mar 16, 2011FY2011P00012B$0.00
—
Feb 16, 2011FY2011P00011C$442,346.00
—
Nov 1, 2010FY2011P00010A$0.00
—
Sep 16, 2010FY2010P00009B$1,952,675.00
—
Aug 25, 2010FY2010P00008A$0.00
—
Jun 22, 2010FY2010P00007D$0.00
—
Mar 25, 2010FY2010P00006M$2,956,209.00
—
Jul 30, 2009FY2009P00005C$5,042,271.00
—
Feb 12, 2009FY2009P00004M$0.00
—
Dec 29, 2008FY2009P00003M$0.00
—
Dec 2, 2008FY2009P00002C$9,337,827.00
—
Sep 18, 2008FY2008P00001M$0.00
—
Jun 30, 2008FY20080—$5,000,000.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.